Sanofi Greece announces the expansion of strategic cooperation with the ATHEX Papaellinas Group, for the full representation of Sanofi General Medicine and Special Care pharmaceutical products in Cyprus. Specifically, in addition to the distribution, from July 19, 2021, the ATHEX Papaellinas Group undertakes all the activities of Sanofi that relate to the above business units on Cypriot territory.
The cooperation is part of Sanofi 's recent adoption of a more flexible business strategy model in the South East Europe region, which focuses, inter alia, on strengthening partnerships with local distribution networks.
Lionel Picard , CEO of Sanofi for Greece and Cyprus , said: “We are pleased to welcome the ATHEX Group. PAPAELLINAS in our network of partners. Our cooperation with one of the most renowned companies for distribution and scientific information of pharmaceutical products in Cyprus will ensure our investment in the local market, ensuring that our medicines will continue to be available safely and reliably to patients, and that Health Professionals will continue to have valid information. Ensuring access to treatment is a top priority for us and we have confidence in the Group that it will fully respond to this important project “.
For his part, Stelios Finikaridis, Senior General Manager of Medicines of the ATHEX Group PAPAELLINAS stated: “We undertake with great satisfaction the role of the exclusive representative of Sanofi for General Medicine and Special Care Pharmaceuticals in the Cypriot market. Our common goal of improving the quality of life of patients and the scientific information of Health Professionals, is the cornerstone for the success of our collaboration, which offers us a new opportunity to fulfill our mission: to do more and more people to live and feel better “.
All points for free rapid test on Tuesday 27 July (catalog)
New protest against precautionary measures by Covid19